Topics: 

– 01 Inaugural session
– 02 New tools and recipes for atrial fibrillation ablation
– 03 Real-world evidence and outstanding clinical practice on cryoballoon Ablation
– 04 Late Breaking Clinical Trials
– 05 Innovation doesn’t end at implant – Advancing cardiac device patient management
– 06 Hein Wellens Memorial ECG Course
– 07 How to in cardiac resynchronisation
– 08 CCM therapy – Optimizing the treatment of Heart Failure with devices
– 09 Neurohormonal disturbances and arrhythmias
– 10 Physiological pacing – current and future directions
– 11 Case Reports session for EHRA
– 12 Cardiac stimulation in the third millennium
– 13 Difficult cases in atrial fibrillation ablation
– 14 NOACs in the Elderly AF patient – Learnings from 10 years of clinical practice
– 15 Less is more – Do we still need an atrial lead for atrial sensing
– 16 Promising advances in heart failure patient management
– 17 The Right Power for the Right Duration – ablate with your eyes open
– 18 Innovation in catheter ablation with real-time, temperature-controlled technology
– 19 The best of Europace Journal 2020
– 20 Structural microdomains in cardiomyocyte arrhythmogenesis
– 21 ECG competition
– 22 Scientific reports
– 23 How to avoid device complications
– 24 Challenging cases in ventricular tachycardia ablation
– 25 The year in cardiovascular medicine
– 26 Ion channel (dys)function
– 27 Live ablation atrial fibrillation
– 28 Supraventricular guidelines 2019 – an update
– 29 Pacing tips and tricks
– 30 Honorary lectures
– 31 Conversations around persistent AF hybrid therapies -1 topic, 2 continents, 3 voices
– 32 Rotational TLE – safe, efficient, and effective outcomes with PROMET and RELEASE
– 33 Advancing Imaging in Electrophysiology – current and future use of dielectric imaging
– 34 The future is here – Miniaturization in implantable cardiac devices
– 35 The new Polar Era – Saturday Morning TalkShow
– 36 Carmeliet – Coraboeuf – Weidmann Lecture
– 37 Live ablation ventricular tachycardia I
– 38 Management of arrhythmias in specific populations – paediatric, congenital and COVID-19
– 39 Sports and sudden cardiac death
– 40 Evidence based atrial fibrillation ablation
– 41 3 years of HD mapping – Do outcomes live up to expectations
– 42 Controversies in management of ventricular arrhythmias
– 43 Pacemakers and ICDs – controversies in device therapy
– 44 Atrial fibrillation live case
– 45 Digital EP new ways to le@rn – training in a new world
– 46 Digital Health – Patient and healthcare provider centric innovations in cardiac rhythm management
– 47 How do we translate the ‘2020 ESC Guidelines on Atrial Fibrillation’ into clinical practice
– 48 The future of EP practice – Do we need a mapping guided patient specific ablation strategy to treat complex arrhythmias
– 49 Best of e-Cardiology
– 50 Inherited cardiomyopathies – What´s new
– 51 Syncope – what is new in therapy
– 52 How to optimise device programming – getting the best for your buck
– 53 How to in atrial fibrillation ablation
– 54 Navigating the patient driven world of cardiac recordings
– 55 Management of patients with CIED complications; facilitating guideline implementation across Europe
– 56 What is the value of the S-ICD (Subcutaneous Implantable Cardiac Device) during a pandemic and beyond
– 57 Young Investigator Award – Basic and Translational Science
– 58 Live ablation ventricular tachycardia II
– 59 How to improve outcomes in atrial fibrillation
– 60 Cardiac arrest in Europe
– 61 Controversies in rhythm control therapy in persistent atrial fibrillation and obesity
– 62 Young Investigator Award – Clinical
– 63 2020 ESC Guidelines on Atrial Fibrillation, focus on oral anticoagulation
– 64 The utilisation of digital methods to improve prediction and recognition of cardiac arrest and to deliver health-care
– 65 Shared decision-making in devices
– 66 Ventricular tachycardia ablation – image-guided ventricular tachycardia ablation
– 67 EHRA Technology and Innovation Awards 2021
– 68 Innovative technology
– 69 What is new in syncope
– 70 EHRA expert consensus statement and practical guide on optimal implantation techniques for conventional pacemakers and ICDs
– 71 What to do if conventional ventricular tachycardia ablation fails
– 72 Robotics in EP – Now a reality
– 73 Cardiac device therapy in 2021 – Increasing the benefits, while preventing side effects
– 74 EHRA practical guide to NOAC use in atrial fibrillation
– 75 Sudden death prevention and ICD therapy – unsolved issues
– 76 Pacing manoeuvers to sort out the tachycardia mechanism
– 77 Ventricular tachycardia ablation live case
– 78 What did change in Heart Failure patient management since the last EHRA
– 79 Inherited cardiomyopathies – how to diagnose and risk stratify primary arrhythmia patients and family members
– 80 The future of electrophysiology
– 81 Closing session